Single Alkyl Phosphonate Modification of the siRNA Backbone in the Seed Region Enhances Specificity and Therapeutic Profile
RNA-seq (gene expression) · human · 110 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 110 samples: 101 distinct titles, 9 of them repeatedGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Single alkyl phosphonate modification of the siRNA backbone in the seed region enhances specificity and therapeutic profileNucleic acids research · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE285764_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1205781 and SRA study SRP555014. Searching any of these in the dataset finder brings you back here.
How we read this: Read from 110 sample titles: 101 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8708392 ALow_MD302_PBS_1 mg/kg_7 Days_liver_A-3_A3
- GSM8708393 ALow_MD302_PBS_1 mg/kg_7 Days_liver_A-2_A2
- GSM8708394 ALow_MD302_PBS_1 mg/kg_7 Days_liver_A-1_A1
- GSM8708395 ALow_MD302_PBS_1 mg/kg_7 Days_liver_A-4_A4
- GSM8708396 ALow_MD302_1708616_10 mg/kg_7 Days_liver_F-3_B19
- GSM8708397 ALow_MD302_1708616_10 mg/kg_7 Days_liver_F-2_B18
- GSM8708398 ALow_MD302_1708616_10 mg/kg_7 Days_liver_F-1_B17
- GSM8708399 ALow_MD302_1708616_10 mg/kg_7 Days_liver_F-4_B20
- GSM8708400 ALow_MD302_1708616_100 mg/kg_7 Days_liver_H-3_C3
- GSM8708401 ALow_MD302_1708616_100 mg/kg_7 Days_liver_H-1_C1
- GSM8708402 ALow_MD302_1708616_100 mg/kg_7 Days_liver_H-2_C2
- GSM8708403 ALow_MD302_1708616_100 mg/kg_7 Days_liver_H-4_C4
- GSM8708404 ALow_MD302_1708616_30 mg/kg_7 Days_liver_G-3_B23
- GSM8708405 ALow_MD302_1708616_30 mg/kg_7 Days_liver_G-2_B22
- GSM8708406 ALow_MD302_1708616_30 mg/kg_7 Days_liver_G-4_B24
- GSM8708407 ALow_MD302_1708616_30 mg/kg_7 Days_liver_G-1_B21
- GSM8708408 ALow_MD303_PBS_1 mg/kg_A-4_F4
- GSM8708409 ALow_MD303_PBS_1 mg/kg_A-3_F3
- GSM8708410 ALow_MD303_PBS_1 mg/kg_A-2_F2
- GSM8708411 ALow_MD303_PBS_1 mg/kg_A-1_F1
- GSM8708412 ALow_MD303_1715157_10 mg/kg_F-2_G18
- GSM8708413 ALow_MD303_1715157_10 mg/kg_F-1_G17
- GSM8708414 ALow_MD303_1715157_10 mg/kg_F-3_G19
- GSM8708415 ALow_MD303_1715157_10 mg/kg_F-4_G20
- GSM8708416 ALow_MD303_1735511_10 mg/kg_M-2_H22
- GSM8708417 ALow_MD303_1735511_10 mg/kg_M-4_H24
- GSM8708418 ALow_MD303_1735511_10 mg/kg_M-3_H23
- GSM8708419 ALow_MD303_1735511_10 mg/kg_M-1_H21
- GSM8708420 ALow_MD303_1715157_100 mg/kg_H-2_H2
- GSM8708421 ALow_MD303_1715157_100 mg/kg_H-4_H4
- GSM8708422 ALow_MD303_1715157_100 mg/kg_H-3_H3
- GSM8708423 ALow_MD303_1715157_100 mg/kg_H-1_H1
- GSM8708424 ALow_MD303_1735511_100 mg/kg_O-2_I6
- GSM8708425 ALow_MD303_1735511_100 mg/kg_O-3_I7
- GSM8708426 ALow_MD303_1735511_100 mg/kg_O-4_I8
- GSM8708427 ALow_MD303_1735511_100 mg/kg_O-1_I5
- GSM8708428 ALow_MD303_1715157_30 mg/kg_G-3_G23
- GSM8708429 ALow_MD303_1715157_30 mg/kg_G-4_G24
- GSM8708430 ALow_MD303_1715157_30 mg/kg_G-1_G21
- GSM8708431 ALow_MD303_1715157_30 mg/kg_G-2_G22
+ 70 more — browse all 110 samples with per-sample file links →
- GSE313756 Tuning siRNA Specificity through Seed Region Incorporation of Deoxyribonucleotide Stereoisomers 104 samples shares specificity, region
- GSE97117 Integrated target discovery screens identify IL11 as novel therapeutic target for fibrosis 212 samples shares therapeutic
- GSE274098 Recurrent FGFR-alterations are frequent oncogenic drivers and therapeutic targets in pediatric low-grade gliomas 68 samples shares therapeutic
- GSE283531 MOZ and HBO1 Histone Acetyltransferase Complexes Are Molecular Dependencies and Therapeutic Targets in NUP98-Rearranged Acute Myeloid Leukemia [RNA-Seq] 54 samples shares therapeutic
- GSE279100 Differential KEAP1/NRF2-mediated signaling widens the therapeutic window of redox-targeting drugs in SCLC therapy [seq] 50 samples shares therapeutic
- GSE286384 METTL3-dependent m6A RNA Modifications Orchestrate the HNF1B-associated Redox and the Metabolic Vulnerability in Cancer [RNA-seq] 40 samples shares modification
- GSE307527 ARID1A and ARID1B preserve B cell identity, prevent myeloid transformation and reveal therapeutic vulnerabilities 30 samples shares therapeutic
- GSE291312 DNA demethylating agents represent a therapeutic opportunity for synovial sarcoma [RNA-Seq 2] 23 samples shares therapeutic
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.